Literature DB >> 30877386

Minimum clinically important difference in outcome scores among patients undergoing cervical laminoplasty.

So Kato1, Yasushi Oshima1, Yoshitaka Matsubayashi1, Yuki Taniguchi1, Sakae Tanaka1, Katsushi Takeshita2.   

Abstract

PURPOSE: Minimum clinically important difference (MCID) represents the smallest change in an outcome measure recognized as clinically meaningful to a patient and is one of the most important psychometric parameters for assessing the postoperative results of spinal surgery. The purpose of the present study was to elucidate MCIDs for four common outcome measures used for degenerative cervical myelopathy in the context of patients undergoing laminoplasty.
METHODS: We retrospectively reviewed a consecutive series of cervical laminoplasties in a single academic institution. Pre- and postoperative Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ), Short Form-36 (SF-36), Neck Disability Index (NDI), and EuroQOL (EQ-5D) scores were obtained. Patients were also asked to answer the anchor question regarding satisfaction with treatment, and the anchor-based method was used to determine cut-off values for MCIDs.
RESULTS: A total of 101 patients were included in the analysis. All outcome scores showed significant improvement postoperatively, with the exception of JOACMEQ bladder function score and SF-36 mental component summary score. Most patients (66%) were at least "somewhat satisfied" with treatment results. Receiver operating characteristic curve analyses revealed MCIDs of 2.5 for JOACEMQ cervical spine function, 13.0 for upper extremity function, 9.35 for lower extremity function, 9.5 for QOL, 3.9 for SF-36 physical component summary score, 4.2 for NDI, and 0.0485 for EQ-5D.
CONCLUSION: The MCIDs of four outcome measures were determined for patients undergoing cervical laminoplasty. These slides can be retrieved under Electronic Supplementary Material.

Entities:  

Keywords:  Cervical laminoplasty; EuroQOL; Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire; Minimum clinically important difference; Neck Disability Index; Short Form-36

Mesh:

Year:  2019        PMID: 30877386     DOI: 10.1007/s00586-019-05945-y

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  23 in total

Review 1.  SF-36 health survey update.

Authors:  J E Ware
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

2.  The minimal detectable change should not replace the minimal important difference.

Authors:  Henrica C W de Vet; Caroline B Terwee
Journal:  J Clin Epidemiol       Date:  2010-07       Impact factor: 6.437

3.  Minimum Clinically Important Difference in SF-36 Scores for Use in Degenerative Cervical Myelopathy.

Authors:  Jetan H Badhiwala; Christopher D Witiw; Farshad Nassiri; Muhammad A Akbar; Blessing Jaja; Jefferson R Wilson; Michael G Fehlings
Journal:  Spine (Phila Pa 1976)       Date:  2018-11-01       Impact factor: 3.468

4.  Neck Disability Index, short form-36 physical component summary, and pain scales for neck and arm pain: the minimum clinically important difference and substantial clinical benefit after cervical spine fusion.

Authors:  Leah Y Carreon; Steven D Glassman; Mitchell J Campbell; Paul A Anderson
Journal:  Spine J       Date:  2010-04-01       Impact factor: 4.166

5.  Patient Satisfaction with Posterior Decompression Surgery for Cervical Ossification of the Posterior Longitudinal Ligament: Prognostic Radiographic Factors and Patient-Reported Outcomes for the Effectiveness of Surgical Treatment.

Authors:  Junichi Ohya; Yasushi Oshima; Hiroyuki Oka; Fumiko Saiki; Yuki Taniguchi; Yoshitaka Matsubayashi; Sakae Tanaka; Hirotaka Chikuda; Katsushi Takeshita
Journal:  World Neurosurg       Date:  2016-09-16       Impact factor: 2.104

6.  Interobserver and intraobserver reliability of the japanese orthopaedic association scoring system for evaluation of cervical compression myelopathy.

Authors:  K Yonenobu; K Abumi; K Nagata; E Taketomi; K Ueyama
Journal:  Spine (Phila Pa 1976)       Date:  2001-09-01       Impact factor: 3.468

7.  Responsiveness of the Chinese versions of the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire and Neck Disability Index in postoperative patients with cervical spondylotic myelopathy.

Authors:  Andy Chien; Dar-Ming Lai; Chih-Hsiu Cheng; Shwu-Fen Wang; Wei-Li Hsu; Jaw-Lin Wang
Journal:  Spine (Phila Pa 1976)       Date:  2015-09-01       Impact factor: 3.468

8.  Assessment of health-related quality of life using the SF-36 in Chinese cervical spondylotic myelopathy patients after surgery and its consistency with neurological function assessment: a cohort study.

Authors:  Yilong Zhang; Feifei Zhou; Yu Sun
Journal:  Health Qual Life Outcomes       Date:  2015-03-26       Impact factor: 3.186

9.  An outcome measure for patients with cervical myelopathy: Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ): Part 1.

Authors:  Mitsuru Fukui; Kazuhiro Chiba; Mamoru Kawakami; Shin-Ichi Kikuchi; Shin-Ichi Konno; Masabumi Miyamoto; Atsushi Seichi; Tadashi Shimamura; Osamu Shirado; Toshihiko Taguchi; Kazuhisa Takahashi; Katsushi Takeshita; Toshikazu Tani; Yoshiaki Toyama; Eiji Wada; Kazuo Yonenobu; Takashi Tanaka; Yoshio Hirota
Journal:  J Orthop Sci       Date:  2007-05-31       Impact factor: 1.601

10.  Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire: part 3. Determination of reliability.

Authors:  Mitsuru Fukui; Kazuhiro Chiba; Mamoru Kawakami; Shinichi Kikuchi; Shinichi Konno; Masabumi Miyamoto; Atsushi Seichi; Tadashi Shimamura; Osamu Shirado; Toshihiko Taguchi; Kazuhisa Takahashi; Katsushi Takeshita; Toshikazu Tani; Yoshiaki Toyama; Kazuo Yonenobu; Eiji Wada; Takashi Tanaka; Yoshio Hirota
Journal:  J Orthop Sci       Date:  2007-08-02       Impact factor: 1.601

View more
  6 in total

1.  Factors associated with postoperative axial symptom after expansive open-door laminoplasty: retrospective study using multivariable analysis.

Authors:  Xiuru Zhang; Yanzheng Gao; Kun Gao; Zhenghong Yu; Dongbo Lv; Hao Ma; Gongwei Zhai
Journal:  Eur Spine J       Date:  2020-06-10       Impact factor: 3.134

2.  Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy: A Randomized Clinical Trial.

Authors:  Zoher Ghogawala; Norma Terrin; Melissa R Dunbar; Janis L Breeze; Karen M Freund; Adam S Kanter; Praveen V Mummaneni; Erica F Bisson; Fred G Barker; J Sanford Schwartz; James S Harrop; Subu N Magge; Robert F Heary; Michael G Fehlings; Todd J Albert; Paul M Arnold; K Daniel Riew; Michael P Steinmetz; Marjorie C Wang; Robert G Whitmore; John G Heller; Edward C Benzel
Journal:  JAMA       Date:  2021-03-09       Impact factor: 56.272

3.  Minimum clinically important change for outcome scores among patients aged 75 or over undergoing lumbar spine surgery.

Authors:  Kosei Nagata; Hideki Nakamoto; So Kato; Yujiro Takeshita; Naohiro Kawamura; Takashi Ono; Akiro Higashikawa; Masayoshi Fukushima; Seiichi Azuma; Nobuhiro Hara; Hiroyuki Oka; Ko Matsudaira; Sakae Tanaka; Yasushi Oshima
Journal:  Eur Spine J       Date:  2021-03-20       Impact factor: 3.134

4.  Neurological recovery rate and minimal clinically important difference as metrics for assessing outcomes of decompressive surgery in patients with degenerative cervical myelopathy.

Authors:  Laura Ganau; Gianfranco K I Ligarotti; Mario Ganau
Journal:  Acta Neurochir (Wien)       Date:  2022-09-22       Impact factor: 2.816

5.  Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Amine Benmassaoud; Suzanne C Freeman; Davide Roccarina; Maria Corina Plaz Torres; Alex J Sutton; Nicola J Cooper; Laura Iogna Prat; Maxine Cowlin; Elisabeth Jane Milne; Neil Hawkins; Brian R Davidson; Chavdar S Pavlov; Douglas Thorburn; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16

6.  Clinical improvement after surgery for degenerative cervical myelopathy; A comparison of Patient-Reported Outcome Measures during 12-month follow-up.

Authors:  Christer Mjåset; John-Anker Zwart; Frode Kolstad; Tore Solberg; Margreth Grotle
Journal:  PLoS One       Date:  2022-03-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.